Leerink Partners Maintains Outperform on Incyte, Lowers Price Target to $150
Benzinga Newsdesk 52 minutes ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Outperform and lowers the price target from $154 to $150.
Leerink Partners analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Outperform and lowers the price target from $154 to $150.